Our previous studies, and others, have demonstrated that irisin-attenuated metabolic disorders, improved insulin sensitivity, and activated insulin signaling pathways contribute to the beneficial effects of irisin [15,16,17]. The gene discussed is INS; the disease is Other metabolic disease.